DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Vietnam
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
PMC logo

Pharmedic Pharmaceutical Medicinal Joint Stock Company Stock Price

HNX:PMC Community·₫1.1t Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

PMC Share Price Performance

₫120,000.00
16000.00 (15.38%)
​
₫120,000.00
16000.00 (15.38%)
​
Price ₫120,000.00
Fri, 11 Sep 26
Share Pricen/a

PMC Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with low risk.

3 Risks
0 Rewards
View Full Analysis

Pharmedic Pharmaceutical Medicinal Joint Stock Company Key Details

₫546.3b

Revenue

₫323.4b

Cost of Revenue

₫222.9b

Gross Profit

₫171.5b

Other Expenses

₫51.4b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
5.50k
40.80%
9.40%
34.4%
View Full Analysis

About PMC

Founded
1981
Employees
494
CEO
Hung Le
WebsiteView website
www.pharmedic.com.vn

Pharmedic Pharmaceutical Medicinal Joint Stock Company manufactures and sells pharmaceutical products in Vietnam. The company offers over the counter drug products, such as medicines from medicinal herbs; minerals and vitamins; eye, ENT, and cough treatment; disinfectants; anti-allergic drugs; gastrointestinal and hepatobiliary drugs; external medications; drugs to treat parasites and bacterial infections analgesic, antipyretic, anti-inflammatory, and gout treatment; cardiovascular and diabetes; and psychoactive drugs. It is also involved in the production of cosmetics, soaps, detergents, polishes, and sanitary preparations; printing and pressing of plastics, aluminum, and paper packaging; production of pharmaceuticals, medicinal materials, and other products; trading of pharmaceuticals, medicinal materials, cosmetics, medical supplies, and other products; and production of medical, dental, orthopaedic, and rehabilitation equipment and instruments. In addition, the company engages in production and trading of chemicals, including insecticidal and antibacterial products used in the household and medical fields; other business support service activities; retail sale of medicines, medical equipment, medical supplies, and cosmetics; production and retail of functional foods; and provision of storage and medicine testing services. The company was founded in 1981 and is headquartered in Ho Chi Minh City, Vietnam.

Recent PMC News & Updates

Recent updates

No updates

Pharmedic Pharmaceutical Medicinal Joint Stock Company Competitors

View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide